Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1990
[Proliferation and differentiation in megakaryopoiesis]L Kanz, R Mertelsmann
Current Opinion in Hematology|May 1, 1996
Ex vivo expansion of hematopoietic precursor cellsW Brugger, L Kanz
Current Opinion in Hematology|November 14, 1998
Expansion of stem and progenitor cellsB L Ziegler, L Kanz
Praxis|January 19, 2006
[Therapy for advanced colorectal carcinoma--new developments and standards]J T Hartmann, L Kanz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensificationL Kanz, W Brugger, R Mertelsmann
Stem Cells (Dayton, Ohio)|September 30, 2000
Ex vivo manipulation of hematopoietic stem and progenitor cellsL Kanz, W Brugger, S Scheding
European Journal of Immunology|April 1, 1987
Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cellsF Emmrich, L Kanz, K Eichmann
Drugs|September 3, 1999
Diagnosis and treatment of patients with testicular germ cell cancerJ T Hartmann, L Kanz, C Bokemeyer
Praxis|December 31, 1997
[Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma]C Bokemeyer, J T Hartmann, L Kanz
Anticancer Research|May 16, 2000
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinomaJ T Hartmann, L Kanz, C Bokemeyer
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1990
[Proliferation and differentiation in megakaryopoiesis]L Kanz, R Mertelsmann
Current Opinion in Hematology|May 1, 1996
Ex vivo expansion of hematopoietic precursor cellsW Brugger, L Kanz
Current Opinion in Hematology|November 14, 1998
Expansion of stem and progenitor cellsB L Ziegler, L Kanz
Praxis|January 19, 2006
[Therapy for advanced colorectal carcinoma--new developments and standards]J T Hartmann, L Kanz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensificationL Kanz, W Brugger, R Mertelsmann
Stem Cells (Dayton, Ohio)|September 30, 2000
Ex vivo manipulation of hematopoietic stem and progenitor cellsL Kanz, W Brugger, S Scheding
European Journal of Immunology|April 1, 1987
Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cellsF Emmrich, L Kanz, K Eichmann
Drugs|September 3, 1999
Diagnosis and treatment of patients with testicular germ cell cancerJ T Hartmann, L Kanz, C Bokemeyer
Praxis|December 31, 1997
[Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma]C Bokemeyer, J T Hartmann, L Kanz
Anticancer Research|May 16, 2000
Phase II study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinomaJ T Hartmann, L Kanz, C Bokemeyer
Pageof 25